LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 179

Search options

  1. Book: Viral hepatitis in children

    Jonas, Maureen M.

    unique features and opportunities

    (Clinical gastroenterology)

    2010  

    Author's details ed. by Maureen M. Jonas
    Series title Clinical gastroenterology
    Language English
    Size X, 174 S. : graph. Darst., 25 cm
    Publisher Humana Press
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    Note Includes bibliographical references and index
    HBZ-ID HT016581606
    ISBN 978-1-60761-372-5 ; 9781607613732 ; 1-60761-372-7 ; 1607613735
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  2. Article ; Online: What do infectious disease specialists think about managing long COVID?

    Lyons, Maureen D / Beekmann, Susan E / Polgreen, Philip M / Marschall, Jonas

    Antimicrobial stewardship & healthcare epidemiology : ASHE

    2023  Volume 3, Issue 1, Page(s) e236

    Abstract: This survey of infectious disease providers on long COVID care revealed a lack of familiarity with existing resources, a sentiment of missing guidelines, and scarcity of dedicated care centers. The low response rate suggests that infectious disease ... ...

    Abstract This survey of infectious disease providers on long COVID care revealed a lack of familiarity with existing resources, a sentiment of missing guidelines, and scarcity of dedicated care centers. The low response rate suggests that infectious disease specialists do not consider themselves as the primary providers of long COVID care.
    Language English
    Publishing date 2023-12-14
    Publishing country England
    Document type Journal Article
    ISSN 2732-494X
    ISSN (online) 2732-494X
    DOI 10.1017/ash.2023.519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat?

    Chappell, Catherine A / Jonas, Maureen M

    The Journal of infectious diseases

    2020  Volume 222, Issue Suppl 9, Page(s) S789–S793

    MeSH term(s) Antiviral Agents/therapeutic use ; Child ; Clinical Trials as Topic ; Disease Eradication ; Early Diagnosis ; Female ; Hepatitis C/diagnosis ; Hepatitis C/drug therapy ; Humans ; Infectious Disease Transmission, Vertical/prevention & control ; Male ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; Pregnancy Complications, Infectious/virology
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2020-11-27
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiaa181
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Presentation, Management, and Outcome of Congenital Portosystemic Shunts in Children: The Boston Children's Hospital Experience.

    Fahmy, Doaa M / Mitchell, Paul D / Jonas, Maureen M

    Journal of pediatric gastroenterology and nutrition

    2022  Volume 75, Issue 1, Page(s) 81–87

    Abstract: Objectives: Congenital portosystemic shunts (CPSS) are rare vascular malformations. We describe presentations, complications, associations, and outcomes of CPSS at Boston Children's Hospital (BCH).: Methods: This was a retrospective review of ... ...

    Abstract Objectives: Congenital portosystemic shunts (CPSS) are rare vascular malformations. We describe presentations, complications, associations, and outcomes of CPSS at Boston Children's Hospital (BCH).
    Methods: This was a retrospective review of children with CPSS at BCH from 2000 to 2020.
    Results: Twenty-nine patients had CPSS (17 girls): 14 extrahepatic (EH) and 15 intrahepatic (IH). At diagnosis, 15 were ≤5 days, 7 <1 year, and 7 >1 year (range 1-19). Median follow-up duration was 5.2 years (interquartile range [IQR] 1.6-10.9) in EH and 2.2 years (0.2-4.2) in IH CPSS. The most common presentation was antenatal ultrasound 13 (45%) followed by hyperammonemia 10 (34%), whereas 6 (21%) were asymptomatic. Complications were noted in 17 (12/14 EH vs 6/15 IH, P = 0.008). Associated anomalies were present in 25 (14/14 EH vs 11/15 IH, P = 0.10). Spontaneous closure was observed in 8 (28%) patients with IH CPSS, all <12 months of age. Ten patients underwent shunt closure 3 (30%) by interventional radiology (IR) and 5 (50%) by surgery, whereas 2 (20%) required both. After therapeutic closure; 8 had improvement, 1 had portal hypertension, and 1 had sepsis and thrombosis. The remaining 11 patients, 8 (42%) were followed without closure: 6 of 8 (75%) EH versus 2 of 11 (18%) IH ( P = 0.02), 2 lost follow-up and 1 with complicated EH CPSS died, unsuitable for therapeutic closure.
    Conclusions: CPSS may be asymptomatic or present with complications. Spontaneous closure of IH shunts may occur in infancy, thus therapeutic closure may be deferred until age ≥ 2 years. IR and surgical closure of CPSS are associated with improvement in the majority of cases.
    MeSH term(s) Child ; Child, Preschool ; Female ; Hospitals ; Humans ; Hypertension, Portal/complications ; Hypertension, Portal/therapy ; Portal Vein/abnormalities ; Portal Vein/diagnostic imaging ; Portal Vein/surgery ; Portasystemic Shunt, Transjugular Intrahepatic ; Pregnancy ; Vascular Malformations/diagnosis ; Vascular Malformations/surgery
    Language English
    Publishing date 2022-04-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603201-1
    ISSN 1536-4801 ; 0277-2116
    ISSN (online) 1536-4801
    ISSN 0277-2116
    DOI 10.1097/MPG.0000000000003450
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: What do infectious disease specialists think about managing long COVID?

    Maureen D. Lyons / Susan E. Beekmann / Philip M. Polgreen / Jonas Marschall

    Antimicrobial Stewardship & Healthcare Epidemiology, Vol

    2023  Volume 3

    Abstract: This survey of infectious disease providers on long COVID care revealed a lack of familiarity with existing resources, a sentiment of missing guidelines, and scarcity of dedicated care centers. The low response rate suggests that infectious disease ... ...

    Abstract This survey of infectious disease providers on long COVID care revealed a lack of familiarity with existing resources, a sentiment of missing guidelines, and scarcity of dedicated care centers. The low response rate suggests that infectious disease specialists do not consider themselves as the primary providers of long COVID care.
    Keywords Infectious and parasitic diseases ; RC109-216 ; Public aspects of medicine ; RA1-1270
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Cambridge University Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Effect of Universal Infant Hepatitis B Virus Immunization on Mother-to-Child Hepatitis B Virus Transmission.

    Nastasio, Silvia / Jonas, Maureen M

    The Journal of infectious diseases

    2019  Volume 220, Issue 7, Page(s) 1089–1090

    MeSH term(s) Child ; Female ; Hepatitis B ; Hepatitis B Surface Antigens ; Hepatitis B virus/immunology ; Humans ; Immunization ; Infant ; Infectious Disease Transmission, Vertical ; Pregnancy
    Chemical Substances Hepatitis B Surface Antigens
    Language English
    Publishing date 2019-01-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiy707
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings.

    Indolfi, Giuseppe / Gonzalez-Peralta, Regino P / Jonas, Maureen M / Sayed, Manal Hamdy-El / Fischler, Björn / Sokal, Etienne / Wirth, Stefan / Nicastro, Emanuele

    Journal of pediatric gastroenterology and nutrition

    2024  Volume 78, Issue 4, Page(s) 957–972

    Abstract: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide, with more than three million viraemic adolescents and children. Treatment of adults with HCV infection and HCV-related liver disease has advanced considerably thanks ... ...

    Abstract Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide, with more than three million viraemic adolescents and children. Treatment of adults with HCV infection and HCV-related liver disease has advanced considerably thanks to development and improvements in therapy. Direct-acting antiviral regimens are safe and effective. Three regimens with pangenotypic activity (glecaprevir/pibrentasvir, sofosbuvir/velpatasvir and sofosbuvir/velpatasvir/voxilaprevir) and three regimens with genotype-specific activity (sofosbuvir/ribavirin, sofosbuvir/ledipasvir and elbasvir/grazoprevir) have been approved with age-specific limitation for treatment of children with chronic hepatitis C by the European Medicines Agency and the United States Food and Drug Administration. The World Health Organization has set the ambitious target to eliminate hepatitis C as a major public health threat by 2030 and based its actions against HCV on the large use of direct acting antivirals. These updated European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommendations on treatment of hepatitis C describe the optimal therapeutic management of adolescents and children with HCV infection including specific indications for those living in resource-limited settings.
    MeSH term(s) Adult ; Child ; Adolescent ; Humans ; Sofosbuvir/therapeutic use ; Hepatitis C, Chronic/drug therapy ; Antiviral Agents/therapeutic use ; Resource-Limited Settings ; Drug Therapy, Combination ; Hepacivirus/genetics ; Sulfonamides/pharmacology ; Sulfonamides/therapeutic use ; Genotype ; Hepatitis C ; Treatment Outcome ; Benzimidazoles ; Benzopyrans ; Carbamates ; Heterocyclic Compounds, 4 or More Rings
    Chemical Substances Sofosbuvir (WJ6CA3ZU8B) ; Antiviral Agents ; velpatasvir (KCU0C7RS7Z) ; Sulfonamides ; Benzimidazoles ; Benzopyrans ; Carbamates ; Heterocyclic Compounds, 4 or More Rings
    Language English
    Publishing date 2024-02-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603201-1
    ISSN 1536-4801 ; 0277-2116
    ISSN (online) 1536-4801
    ISSN 0277-2116
    DOI 10.1002/jpn3.12160
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Hepatitis B virus infection in children.

    Jonas, Maureen M

    Clinical liver disease

    2013  Volume 2, Issue 1, Page(s) 41–44

    Language English
    Publishing date 2013-03-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2657644-2
    ISSN 2046-2484
    ISSN 2046-2484
    DOI 10.1002/cld.125
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Review.

    Jonas, Maureen M / Lee, Christine

    Gastroenterology & hepatology

    2016  Volume 2, Issue 2, Page(s) 90

    Language English
    Publishing date 2016-07-13
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2386402-3
    ISSN 1554-7914
    ISSN 1554-7914
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A quality improvement intervention to decrease the decline in renal function in pediatric liver transplant recipients.

    Batsis, Irini / Elisofon, Scott / Ferguson, Michael / Jonas, Maureen / Kimball, Brendan / Lee, Christine / Mitchell, Paul / Fawaz, Rima

    Pediatric transplantation

    2023  Volume 27, Issue 4, Page(s) e14506

    Abstract: ... LT) recipients. The prevalence of estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m ... < 90 at 3 m post-LT was 19% in pre- versus 14% in the post-intervention period (p = .31); at 12 months ...

    Abstract Background: Chronic kidney disease (CKD) impacts long-term morbidity in pediatric liver transplant (LT) recipients. The prevalence of estimated glomerular filtration rate (eGFR) < 90 mL/min/1.73 m
    Methods: Children post-LT under 19 years from 2010 to 2018 were included. Three QI interventions were implemented starting 1/2016: documentation of blood pressure percentile (BP%) and eGFR, documentation of a kidney management plan if either was abnormal, and amlodipine initiation prior to hospital discharge after LT. We compared the prevalence of eGFR < 90 at 3, 12, and 24 months after LT in the pre- and post-intervention period.
    Results: 68 patients in pre- and 42 in post-intervention periods met inclusion criteria. Pre-intervention BP%, eGFR, and kidney management plan were documented at 25%, 10%, and 22%, compared to 71%, 83%, and 71% post-intervention, respectively. 22% of patients were started on amlodipine prior to discharge from LT in the pre- versus 74% in the post-intervention period. Prevalence of eGFR < 90 at 3 m post-LT was 19% in pre- versus 14% in the post-intervention period (p = .31); at 12 months 24% versus 7% (p = .01) and at 24 months 16% versus 6% (p = .13), respectively. Significant non-modifiable risk factors for eGFR < 90 were malignancy (RR = 4.5, p < .0001), metabolic disorder (RR = 2.6, p = .02), and age at transplant (7% increased risk per year of age, p = .007).
    Conclusion: By improving documentation of BP%, eGFR, and kidney management plan, the prevalence of eGFR < 90 was decreased by a relative 74% and 60% at 12 and 24 months post-LT, respectively.
    MeSH term(s) Humans ; Child ; Liver Transplantation/adverse effects ; Quality Improvement ; Glomerular Filtration Rate/physiology ; Kidney/physiology ; Risk Factors ; Amlodipine ; Retrospective Studies
    Chemical Substances Amlodipine (1J444QC288)
    Language English
    Publishing date 2023-03-20
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1390284-2
    ISSN 1399-3046 ; 1397-3142
    ISSN (online) 1399-3046
    ISSN 1397-3142
    DOI 10.1111/petr.14506
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top